Group 6 Copy 425
0
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    A Search for the Origins of White-Nose Syndrome

    I will be searching caves across northeastern China for the fungus which causes a devastating disease of bats...

    Are cities hostile environments for honey bees?

    Pollinators are vital to the maintenance of life. They assist flowering plants (including most human food crops...

    Help me sequence wild populations of a medicinal plant (Pilocarpus)

    I'm studying an important medicinal plant in the citrus family, commonly known as Jaborandi(Pilocarpus). Compounds...

    Backer Badge Funded

    A biology project funded by 47 people